Evaluation of the food effect on a drospirenone only contraceptive containing 4 mg administered with and without high-fat breakfast in a randomised trial
Abstract Background The objective of the present trial was to assess the difference in pharmacokinetics (PK) of an oral test preparation containing 4 mg drospirenone (DRSP) under fasting conditions compared to PK upon food intake after single dose administration. Methods Open label, single centre, t...
Saved in:
Main Authors: | P.-A. Regidor (Author), W. H. Richter (Author), R. Koytchev (Author), V. Kirkov (Author), E. Colli (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and cardiovascular safety of the new estrogen-free contraceptive pill containing 4 mg drospirenone alone in a 24/4 regime
by: Santiago Palacios, et al.
Published: (2020) -
The drospirenone only pill as a contraceptive option for breastfeeding women: First data on users' acceptability and newborn development
by: Pedro Antonio Regidor, et al.
Published: (2024) -
Therapeutic non-contraceptive properties of the drug containing ethinylestradiol 0.03 mg and drospirenone 3 mg
by: Natalia V Artymuk, et al.
Published: (2019) -
Drospirenone-containing contraception: curative and preventive aspects of use
by: A V Ledina, et al.
Published: (2015) -
Efficacy and safety of drospirenone-containing microdosage combined oral contraceptive use with starting contraception
by: A R Khachaturian, et al.
Published: (2018)